Tumor necrosis factor therapy and the risk of serious infection and malignancy in patients with early rheumatoid arthritis: a meta-analysis of randomized controlled trials.

Thompson, Andrew E

Tumor necrosis factor therapy and the risk of serious infection and malignancy in patients with early rheumatoid arthritis: a meta-analysis of randomized controlled trials. [electronic resource] - Arthritis and rheumatism Jun 2011 - 1479-85 p. digital

Publication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't

1529-0131

10.1002/art.30310 doi


Adult
Antirheumatic Agents--adverse effects
Arthritis, Rheumatoid--drug therapy
Communicable Diseases--epidemiology
Drug Therapy, Combination
Female
Humans
Male
Methotrexate--adverse effects
Middle Aged
Neoplasms--chemically induced
Randomized Controlled Trials as Topic
Risk
Treatment Outcome
Tumor Necrosis Factor-alpha--antagonists & inhibitors